Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct 15;18(20):4007-12.
doi: 10.1093/hmg/ddp322. Epub 2009 Jul 23.

Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15

Affiliations

Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15

Kaisu Keskitalo et al. Hum Mol Genet. .

Abstract

A cluster of three nicotinic acetylcholine receptor genes on chromosome 15 (CHRNA5/CHRNA3/CHRNB4) has been shown to be associated with nicotine dependence and smoking quantity. The aim of this study was to clarify whether the variation at this locus regulates nicotine intake among smokers by using the level of a metabolite of nicotine, cotinine, as an outcome. The number of cigarettes smoked per day (CPD) and immune-reactive serum cotinine level were determined in 516 daily smokers (age 30-75 years, 303 males) from the population-based Health2000 study. Association of 21 SNPs from a 100 kb region of chromosome 15 with cotinine and CPD was examined. SNP rs1051730 showed the strongest association to both measures. However, this SNP accounted for nearly a five-fold larger proportion of variance in cotinine levels than in CPD (R(2) 4.3% versus 0.9%). The effect size of the SNP was 0.30 for cotinine level, whereas it was 0.13 for CPD. Variation at CHRNA5/CHRNA3/CHRNB4 cluster influences nicotine level, measured as cotinine, more strongly than smoking quantity, measured by CPD, and appears thus to be involved in regulation of nicotine levels among smokers.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Relationship between number of cigarettes smoked daily (CPD) and immune-reactive serum cotinine levels with a lowess curve within daily smokers (n = 516).
Figure 2.
Figure 2.
Results of the association analysis for immune-reactive cotinine level (ng/ml) and number of cigarettes smoked per day (CPD).
Figure 3.
Figure 3.
Mean immune-reactive cotinine levels (ng/ml) and their standard errors corresponding to different genotypes of rs1051730 within daily smokers successfully genotyped (n = 515).

Similar articles

Cited by

References

    1. Li M.D., Burmeister M.B. New insights into the genetics of addiction. Nat. Rev. Genet. 2009;10:225–231. - PMC - PubMed
    1. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008: the MPOWER Package. Geneva, Switzerland: World Health Organization; 2008.
    1. Benowitz N. Pharmacology of nicotine: addiction and therapeutics. Ann. Rev. Pharmacol. Toxicol. 1996;36:597–613. - PubMed
    1. Collins A.C., Salminen O., Marks M.J., Whiteaker P., Grady S.R. The road to discovery of neuronal nicotinic cholinergic receptor subtypes. In: Henningfield J.E., London E.D., Pogun S., editors. Nicotine Psychopharmacology. Heidelberg, Germany: Spriger-Verlag; 2009. pp. 85–112. - PMC - PubMed
    1. Bierut L.J., Stitzel J.A., Wang J.C., Hinrichs A.L., Grucza R.A., Xuei X., Saccone N.L., Saccone S.F., Bertelsen S., Fox L., et al. Variants in nicotinic receptors and risk for nicotine dependence. Am. J. Psychiatry. 2008;165:1163–1171. - PMC - PubMed

Publication types